Mumps - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Mumps - Pipeline Review, H2 2016

Mumps - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Mumps - Pipeline Review, H2 2016
Published Jul 20, 2016
44 pages — Published Jul 20, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Mumps - Pipeline Review, H2 2016, provides an overview of the Mumps pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Mumps and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Mumps
- The report reviews pipeline therapeutics for Mumps by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Mumps therapeutics and enlists all their major and minor projects
- The report assesses Mumps therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Mumps

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Mumps
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Mumps pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the mos

  
Source:
Document ID
GMDHC8243IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Mumps Overview61
Therapeutics Development72
  Pipeline Products for Mumps Overview71
  Pipeline Products for Mumps Comparative Analysis81
Mumps Therapeutics under Development by Companies91
Mumps Therapeutics under Investigation by Universities/Institutes101
Mumps Pipeline Products Glance113
  Late Stage Products111
  Clinical Stage Products121
  Early Stage Products131
Mumps Products under Development by Companies141
Mumps Products under Investigation by Universities/Institutes151
Mumps Companies Involved in Therapeutics Development168
  Beijing Minhai Biotechnology Co., Ltd161
  Beijing Tiantan Biological Products Co., Ltd.171
  China National Pharmaceutical Group Corporation181
  Daiichi Sankyo Company, Limited191
  GlaxoSmithKline Plc201
  Prometheon Pharma, LLC211
  Sinovac Biotech Ltd.221
  Zydus Cadila Healthcare Limited231
Mumps Therapeutics Assessment246
  Assessment by Monotherapy Products241
  Assessment by Combination Products251
  Assessment by Route of Administration262
  Assessment by Molecule Type282
Drug Profiles3010
  (measles + mumps + rubella + varicella) (tetravalent) vaccine Drug Profile301
  (measles + mumps + rubella + varicella) vaccine Drug Profile311
  (measles + mumps + rubella) vaccine Drug Profile321
  (measles + mumps + rubella) vaccine Drug Profile331
  (measles + mumps + rubella) vaccine Drug Profile341
  (measles [strain Schwarz] + mumps [strain RIT 4385] + rubella [strain Wistar RA 27/3]) vaccine Drug Profile351
  measles + mumps + rubella + varicella vaccine Drug Profile361
  mumps vaccine Drug Profile371
  mumps vaccine Drug Profile381
  VN-0102 Drug Profile391
Mumps Dormant Projects401
Mumps Product Development Milestones412
  Featured News &Press Releases411
    Jun 13, 2012: UGA researcher developing new vaccine to fight resurging mumps virus412
Appendix432
  Methodology431
  Coverage431
  Secondary Research431
  Primary Research431
  Expert Panel Validation431
  Contact Us431
  Disclaimer441

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Mumps - Pipeline Review, H2 2016" Jul 20, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Mumps-Pipeline-Review-H2-2016-2088-16217>
  
APA:
Global Markets Direct - Market Research. (2016). Mumps - Pipeline Review, H2 2016 Jul 20, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Mumps-Pipeline-Review-H2-2016-2088-16217>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.